Exposure to anti-malarial drugs and monitoring of adverse drug reactions using toll-free mobile phone calls in private retail sector in Sagamu, Nigeria: implications for pharmacovigilance
about
Patient Participation and the Use of Ehealth Tools for PharmacoviliganceA systematic review of the role of proprietary and patent medicine vendors in healthcare provision in NigeriaCell phone-based system (Chaak) for surveillance of immatures of dengue virus mosquito vectorsOngoing challenges in pharmacovigilance.Systematic review on what works, what does not work and why of implementation of mobile health (mHealth) projects in Africa.Health worker perceptions of integrating mobile phones into community case management of malaria in Saraya, Senegal.Feasibility and cost of using mobile phones for capturing drug safety information in peri-urban settlement in Ghana: a prospective cohort study of patients with uncomplicated malariaDifferences in malaria care seeking and dispensing outcomes for adults and children attending drug vendors in Nasarawa, Nigeria.Mobile phones improve case detection and management of malaria in rural Bangladesh.Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d'Ivoire.Perspectives on the future of postmarket vaccine safety surveillance and evaluation.
P2860
Q26752684-813B936D-44EB-435E-BAA4-EEC1B2EEA93EQ28543137-85678D9F-ED0E-4951-AA8E-8589C2E50CC9Q28658881-467A1C88-D0DF-4BB3-98DF-AA0EA9B26F6EQ34417013-C53C60E8-1751-40A1-8220-87C6A19C1C62Q35098859-8C09E106-7EA1-41D9-9456-18CE900E25AAQ35333379-73593382-0E4A-40AF-9DB7-FE4EDE0A91E7Q36190060-24E44CE2-C062-47A4-8E3C-83FBE4B62642Q36417385-6B4B705F-1AA1-4ACD-8CBA-73A7D187AB2BQ36649273-6AFD4902-6F66-48AB-9632-8B8A2375DC90Q37555147-A1B0EAE0-5588-4E14-9840-7DA48444EDB5Q38194216-EA4FCAE1-3367-4BE3-BCD3-322A7C19E2B5
P2860
Exposure to anti-malarial drugs and monitoring of adverse drug reactions using toll-free mobile phone calls in private retail sector in Sagamu, Nigeria: implications for pharmacovigilance
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Exposure to anti-malarial drug ...... ications for pharmacovigilance
@ast
Exposure to anti-malarial drug ...... ications for pharmacovigilance
@en
type
label
Exposure to anti-malarial drug ...... ications for pharmacovigilance
@ast
Exposure to anti-malarial drug ...... ications for pharmacovigilance
@en
prefLabel
Exposure to anti-malarial drug ...... ications for pharmacovigilance
@ast
Exposure to anti-malarial drug ...... ications for pharmacovigilance
@en
P2093
P2860
P50
P356
P1433
P1476
Exposure to anti-malarial drug ...... ications for pharmacovigilance
@en
P2093
Azeez Tella
Bilqees Sanusi
Fatai A Fehintola
Mufliat O Akinwunmi
Olajide O Ayilara
Olubukola A Tikare
Olubusola Ojo
Olumide A T Ogundahunsi
Omobola A Ogundahunsi
Taofeeqah T Ademola
P2860
P2888
P356
10.1186/1475-2875-10-230
P577
2011-08-09T00:00:00Z
P5875
P6179
1041162598